Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

The agency suggested that clinical trials in humans may be required for updated Covid shots, raising questions about whether ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

01. Confusion over the Food and Drug Administration’s delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend when the agency’s commissioner, Marty Makary ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...